Good news for higher-risk groups: the updated Pfizer-BioNTech booster shows a notably stronger immune response in adults 65+ and those with health conditions.
Exciting news from Pfizer and BioNTech! Their updated COVID-19 vaccine is showing promising results in older adults and those with underlyin









